{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T01:34:24Z","timestamp":1770687264707,"version":"3.49.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Economics & Human Biology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ehb.2025.101570","type":"journal-article","created":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:19:28Z","timestamp":1767140368000},"page":"101570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The impact of prescription drug monitoring programs on functional health"],"prefix":"10.1016","volume":"60","author":[{"given":"Anca M.","family":"Cotet-Grecu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2996-5717","authenticated-orcid":false,"given":"Danielle","family":"Zanzalari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1089\/jwh.2019.8234","article-title":"Prescription opioids and patient sex: a national cross-sectional study","volume":"30","author":"Agnoli","year":"2021","journal-title":"J. Women\u2019s Health"},{"key":"10.1016\/j.ehb.2025.101570_bib2","doi-asserted-by":"crossref","first-page":"102446","DOI":"10.1016\/j.labeco.2023.102446","article-title":"Opioids and the labor market","volume":"85","author":"Aliprantis","year":"2023","journal-title":"Labour Econ."},{"key":"10.1016\/j.ehb.2025.101570_bib3","doi-asserted-by":"crossref","unstructured":"Balestra, S., Liebert, H., Maestas N., Sherry, T.B., 2021. Behavioral responses to supply-side drug policy during the opioid epidemic. NBER Work. Pap. No 29596.","DOI":"10.3386\/w29596"},{"issue":"3","key":"10.1016\/j.ehb.2025.101570_bib4","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/coep.12684","article-title":"Beyond opioids: the effect of prescription drug monitoring programs on non\u2010opioid drug prescribing","volume":"43","author":"Beheshti","year":"2025","journal-title":"Contemp. Econ. Policy"},{"issue":"6","key":"10.1016\/j.ehb.2025.101570_bib5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/M18-1243","article-title":"Opioid prescribing in the United States before and after the Centers for Disease Control and Prevention\u2019s 2016 Opioid Guideline","volume":"169","author":"Bohnert","year":"2018","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1257\/pol.20160094","article-title":"The effect of prescription drug monitoring programs on opioid utilization in medicare","volume":"10","author":"Buchmueller","year":"2018","journal-title":"Am. Econ. J. Econ. Policy"},{"issue":"2","key":"10.1016\/j.ehb.2025.101570_bib7","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jeconom.2020.12.001","article-title":"Difference-in-differences with multiple time periods","volume":"225","author":"Callaway","year":"2021","journal-title":"J. Econometrics"},{"issue":"4","key":"10.1016\/j.ehb.2025.101570_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jamapediatrics.2018.5550","article-title":"2018 update on pediatric medical overuse: a review","volume":"173","author":"Coon","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"5","key":"10.1016\/j.ehb.2025.101570_bib9","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.annemergmed.2019.04.019","article-title":"Risk factors for misuse of prescribed opioids: a systematic review and meta-analysis","volume":"74","author":"Cragg","year":"2019","journal-title":"Ann. Emerg. Med."},{"issue":"4","key":"10.1016\/j.ehb.2025.101570_bib10","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0167-6296(02)00007-3","article-title":"The reliability of self-assessed health status","volume":"21","author":"Crossley","year":"2002","journal-title":"J. Health Econ."},{"issue":"162","key":"10.1016\/j.ehb.2025.101570_bib11","article-title":"Prescription opioid use among adults with chronic pain: United States, 2019","author":"Dahlhamer","year":"2021","journal-title":"Natl. Health Stat. Rep."},{"issue":"9","key":"10.1016\/j.ehb.2025.101570_bib12","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1526-4637.2012.01467.x","article-title":"Medical and psychological risks and consequences of long-term opioid therapy in women","volume":"13","author":"Darnall","year":"2012","journal-title":"Pain. Med."},{"issue":"3","key":"10.1016\/j.ehb.2025.101570_bib13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/soej.12481","article-title":"Prescription drug monitoring programs, opioid abuse, and crime","volume":"87","author":"Dave","year":"2021","journal-title":"South. Econ. J."},{"issue":"3","key":"10.1016\/j.ehb.2025.101570_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00148-025-01111-5","article-title":"Fighting abuse with prescription tracking: mandatory drug monitoring and intimate partner violence","volume":"38","author":"Dave","year":"2025","journal-title":"J. Popul. Econ."},{"issue":"6402","key":"10.1016\/j.ehb.2025.101570_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1126\/science.aat4595","article-title":"Opioid prescribing decreases after learning of a patient\u2019s fatal overdose","volume":"361","author":"Doctor","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.ehb.2025.101570_bib16","unstructured":"Dydyk, A.M., Nitesh, K.J., Gupta, M., 2024. Opioid use disorder\u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553166\/#\u3009."},{"issue":"1\u20132","key":"10.1016\/j.ehb.2025.101570_bib17","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2010.05.017","article-title":"Risks for opioid abuse and dependence among recipients of chronic opioid therapy: results from the TROUP study","volume":"112","author":"Edlund","year":"2010","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pain.2006.06.009","article-title":"Critical issues on opioids in chronic non-cancer pain","volume":"125","author":"Eriksen","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.ehb.2025.101570_bib19","series-title":"Balancing societal and individual benefits and risks of prescription opioid use","article-title":"Trends in opioid use, harms, and treatment. Pain Management and the Opioid Epidemic","author":"Ford","year":"2017"},{"issue":"2","key":"10.1016\/j.ehb.2025.101570_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/mpr.232","article-title":"Understanding the patterns and distribution of opioid analgesic dependence symptoms using a latent empirical approach","volume":"17","author":"Ghandour","year":"2008","journal-title":"Int. J. Methods Psychiatr. Res."},{"issue":"2","key":"10.1016\/j.ehb.2025.101570_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fj.202002125R","article-title":"Women, opioid use and addiction","volume":"35","author":"Goetz","year":"2021","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pam.22098","article-title":"Mandatory access prescription drug monitoring programs and prescription drug abuse","volume":"38","author":"Grecu","year":"2019","journal-title":"J. Policy Anal. Manag."},{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib23","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1186\/s12889-023-16256-9","article-title":"Prescription drug monitoring programs use mandates and prescription stimulant and depressant quantities","volume":"23","author":"Gunadi","year":"2023","journal-title":"BMC Public Health"},{"issue":"26","key":"10.1016\/j.ehb.2025.101570_bib24","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States. 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"Morb. Mortal. Wkly. Rep. (MMWR)"},{"issue":"2","key":"10.1016\/j.ehb.2025.101570_bib25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/1475-6773.13548","article-title":"\u201cThe importance of data source in prescription drug monitoring program research\u201d","volume":"56","author":"Horwitz","year":"2021","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.ehb.2025.101570_bib26","series-title":"\u201cRelieving Pain in America :A Blueprint for Transforming Prevention, Care, Education, and Research","author":"Institute of Medicine (US) Committee on Advancing Pain Research, Care, and Education","year":"2011"},{"key":"10.1016\/j.ehb.2025.101570_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.labeco.2023.102358","article-title":"Effects of prescription opioids on employment, earnings, marriage, disability and mortality: Evidence from state opioid control policies","volume":"82","author":"Kaestner","year":"2023","journal-title":"Labour Econ."},{"key":"10.1016\/j.ehb.2025.101570_bib28","series-title":"Opioids for the masses: Welfare tradeoffs in the regulation of narcotic pain medications","author":"Kilby","year":"2021"},{"key":"10.1016\/j.ehb.2025.101570_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2020.102408","article-title":"Must-access Prescription drug monitoring programs and the opioid epidemic: The unintended consequences","volume":"75","author":"Kim","year":"2021","journal-title":"J. Health Econ."},{"key":"10.1016\/j.ehb.2025.101570_bib30","doi-asserted-by":"crossref","unstructured":"Mallatt, J., 2018. The effect of prescription drug monitoring programs on opioid prescriptions and heroin crime rates. Available at SSRN: https:\/\/ssrn.com\/abstract=3050692 or http:\/\/dx.doi.org\/10.2139\/ssrn.3050692.","DOI":"10.2139\/ssrn.3050692"},{"issue":"1\u20133","key":"10.1016\/j.ehb.2025.101570_bib31","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2008.06.013","article-title":"Correlates of extramedical use of OxyContin versus other analgesic opioids among the US general population","volume":"99","author":"Martins","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ehb.2025.101570_bib32","doi-asserted-by":"crossref","unstructured":"Meinhofer, A., 2016. The war on drugs: estimating the effect of prescription drug supply-side interventions. Available at SSRN: https:\/\/ssrn.com\/abstract=2716974 or http:\/\/dx.doi.org\/10.2139\/ssrn.2716974.","DOI":"10.2139\/ssrn.2716974"},{"issue":"2","key":"10.1016\/j.ehb.2025.101570_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1001\/jamainternmed.2018.5748","article-title":"2018 Update on medical overuse","volume":"179","author":"Morgan","year":"2019","journal-title":"JAMA Intern. Med."},{"issue":"5","key":"10.1016\/j.ehb.2025.101570_bib34","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1526-4637.2011.01062.x","article-title":"Prescription drug monitoring programs and death rates from drug overdose","volume":"12","author":"Paulozzi","year":"2011","journal-title":"Pain. Med."},{"issue":"10","key":"10.1016\/j.ehb.2025.101570_bib35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pds.1626","article-title":"Recent changes in drug poisoning mortality in the United States by urban\u2013rural status and by drug type","volume":"17","author":"Paulozzi","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"5","key":"10.1016\/j.ehb.2025.101570_bib36","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/jcpt.13114","article-title":"Opioid withdrawal symptoms, a consequence of chronic opioid use and opioid use disorder: current understanding and approaches to management","volume":"45","author":"Pergolizzi","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"issue":"5","key":"10.1016\/j.ehb.2025.101570_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2025.0809","article-title":"Estimates of illicit opioid use in the US","volume":"6","author":"Powell","year":"2025","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.ehb.2025.101570_bib38","first-page":"41","article-title":"Prescription opioid usage and abuse relationships: an evaluation of state prescription drug monitoring program efficacy","volume":"3","author":"Reisman","year":"2009","journal-title":"Subst. Abus. Res. Treat."},{"issue":"15","key":"10.1016\/j.ehb.2025.101570_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.15585\/mmwr.mm7215a1","article-title":"Chronic Pain Among Adults \u2014 United States, 2019\u20132021","volume":"72","author":"Rikard","year":"2023","journal-title":"Morb. Mortal. Wkly. Rep. (MMWR)."},{"key":"10.1016\/j.ehb.2025.101570_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhealeco.2020.102397","article-title":"Can policy affect initiation of addictive substance use? Evidence from opioid prescribing","volume":"76","author":"Sacks","year":"2021","journal-title":"J. Health Econ."},{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib41","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jeconom.2020.06.003","article-title":"Doubly robust difference-in-differences estimators","volume":"219","author":"Sant\u2019Anna","year":"2020","journal-title":"J. Econometrics."},{"issue":"5","key":"10.1016\/j.ehb.2025.101570_bib42","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1111\/ajad.13289","article-title":"Recent trends in prescription drug misuse in the United States by age, race\/ethnicity, and sex","volume":"31","author":"Schepis","year":"2022","journal-title":"Am. J. Addict."},{"issue":"11","key":"10.1016\/j.ehb.2025.101570_bib43","doi-asserted-by":"crossref","first-page":"298","DOI":"10.15585\/mmwr.mm6911a5","article-title":"Variation in adult outpatient opioid prescription dispensing by age and sex \u2013 United States, 2008-2018","volume":"69","author":"Schieber","year":"2020","journal-title":"Morb. Mortal. Wkly. Rep. (MMWR)"},{"issue":"3","key":"10.1016\/j.ehb.2025.101570_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/coep.12607","article-title":"The effect of Prescription Drug Monitoring Programs on county-level opioid prescribing practices and spillovers","volume":"41","author":"Shakya","year":"2023","journal-title":"Contemp. Econ. Policy"},{"issue":"10","key":"10.1016\/j.ehb.2025.101570_bib45","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jpain.2018.04.004","article-title":"Prescription medication use among community-based US adults with chronic low back pain: a cross-sectional population based study","volume":"19","author":"Shmagel","year":"2018","journal-title":"J. Pain."},{"key":"10.1016\/j.ehb.2025.101570_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.105946","article-title":"Gender differences in prescription opioid use and misuse: Implications for men\u2019s health and the opioid epidemic","volume":"131","author":"Silver","year":"2020","journal-title":"Prev. Med."},{"key":"10.1016\/j.ehb.2025.101570_bib47","series-title":"Evaluation of prescription drug monitoring programs","author":"Simeone","year":"2006"},{"key":"10.1016\/j.ehb.2025.101570_bib48","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.drugalcdep.2017.08.027","article-title":"Age trends in rates of substance use disorders across ages 18-90: differences by gender and race\/ethnicity","volume":"180","author":"Vasilenko","year":"2017","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.ehb.2025.101570_bib49","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12877-020-01516-9","article-title":"Self-rated health and objective health status as predictors of all-cause mortality among older people: a prospective study with a 5-, 10-, and 27-year follow-up","volume":"20","author":"Wuorela","year":"2020","journal-title":"BMC Geriatr."}],"container-title":["Economics & Human Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570677X25001030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570677X25001030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T09:41:52Z","timestamp":1770630112000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570677X25001030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":49,"alternative-id":["S1570677X25001030"],"URL":"https:\/\/doi.org\/10.1016\/j.ehb.2025.101570","relation":{},"ISSN":["1570-677X"],"issn-type":[{"value":"1570-677X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of prescription drug monitoring programs on functional health","name":"articletitle","label":"Article Title"},{"value":"Economics & Human Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ehb.2025.101570","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101570"}}